Plasma Fractionation Market Analysis: Research Insight, Size, Share Industry Growth Factors, Business Demand, Trends, Forecast 2028
In April 2023, CSL (Australia) received Food and Drug Administration (FDA) approval for the 50mL/10gm prefilled syringe for Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid for patients suffering from PI and CIPD.
View full press release